Search

Your search keyword '"Trench, G. (Georgia)"' showing total 93 results

Search Constraints

Start Over You searched for: Author "Trench, G. (Georgia)" Remove constraint Author: "Trench, G. (Georgia)"
93 results on '"Trench, G. (Georgia)"'

Search Results

1. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

2. Rare germline copy number variants (CNVs) and breast cancer risk

3. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes

4. CYP3A7*1C allele:linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

5. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

6. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

7. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis

8. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

9. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

10. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

11. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

12. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

13. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

14. Homologous recombination DNA repair defects in PALB2-associated breast cancers

15. Genome-wide association study of germline variants and breast cancer-specific mortality

16. Erratum: Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature communications (2019) 10 1 (431))

17. Shared heritability and functional enrichment across six solid cancers

18. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

19. Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer

20. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

21. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

22. The BRCA2 c.68‐7T > A variant is not pathogenic:a model for clinical calibration of spliceogenicity

23. Body mass index and breast cancer survival:a Mendelian randomization analysis

24. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

25. Body mass index and breast cancer survival

26. Reproductive profiles and risk of breast cancer subtypes

27. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

28. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

29. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

30. Age-And tumor subtype-specific breast cancer risk estimates for CHEK2∗1100delC Carriers

31. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

32. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

33. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

34. Genetic predisposition to ductal carcinoma in situ of the breast

35. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

36. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

37. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

38. Fine-mapping of the 1p11.2 breast cancer susceptibility locus

39. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

40. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

41. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

42. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

43. Prediction of breast cancer risk based on profiling with common genetic variants

44. Identification of novel genetic markers of breast cancer survival

45. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

46. Common germline polymorphisms associated with breast cancer-specific survival

47. Annexin A1 expression in a pooled breast cancer series: Association with tumor subtypes and prognosis

48. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

49. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

50. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

Catalog

Books, media, physical & digital resources